Although not specifically approved for the treatment of bleeding peptic ulcers, proton pump inhibitors (PPIs) such as omeprazole (Losec AstraZeneca, Luton, UK) are widely used for this indication.

Objective: To evaluate the bioequivalence of two enteric-coated formulations of omeprazole, Losec ® (reference) and Omepradex ® (test). It is hypothesised that formulation differences may be ...

AstraZeneca has agreed to sell most global commercial rights to its gastro drug Losec (omeprazole) and associated brands to Germany’s Cheplapharm Arzneimittel in a deal worth up to $309 million.